149 related articles for article (PubMed ID: 22871645)
41. [Antifungal effects in vitro of jasmon and some similar compounds. Structure-activity relationship].
Millet-Clerc J; Michel D; Chaumont JP
Ann Pharm Fr; 1989; 47(3):157-61. PubMed ID: 2699545
[TBL] [Abstract][Full Text] [Related]
42. 5-(Alkylsulfonyl)salicylanilides as potential dental antiplaque agents.
Clark MT; Coburn RA; Evans RT; Genco RJ
J Med Chem; 1986 Jan; 29(1):25-9. PubMed ID: 3941411
[TBL] [Abstract][Full Text] [Related]
43. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
Jo Siu WJ; Tatsumi Y; Senda H; Pillai R; Nakamura T; Sone D; Fothergill A
Antimicrob Agents Chemother; 2013 Apr; 57(4):1610-6. PubMed ID: 23318803
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological evaluation of hydrazone derivatives as antifungal agents.
Casanova BB; Muniz MN; de Oliveira T; de Oliveira LF; Machado MM; Fuentefria AM; Gosmann G; Gnoatto SC
Molecules; 2015 May; 20(5):9229-41. PubMed ID: 26007181
[TBL] [Abstract][Full Text] [Related]
45. Halogenated benzoate derivatives of altholactone with improved anti-fungal activity.
Euanorasetr J; Junhom M; Tantimavanich S; Vorasin O; Munyoo B; Tuchinda P; Panbangred W
J Asian Nat Prod Res; 2016 May; 18(5):462-74. PubMed ID: 26765144
[TBL] [Abstract][Full Text] [Related]
46. Expression, purification and in vitro antifungal activity of acidic mammalian chitinase against Candida albicans, Aspergillus fumigatus and Trichophyton rubrum strains.
Chen L; Shen Z; Wu J
Clin Exp Dermatol; 2009 Jan; 34(1):55-60. PubMed ID: 19076793
[TBL] [Abstract][Full Text] [Related]
47. A new acridone with antifungal properties against Candida spp. and dermatophytes, and antibiofilm activity against C. albicans.
de Oliveira DBC; Silva LB; da Silva BV; Borges TC; Marques BC; Dos Santos MB; de Oliveira LF; Bolzani VS; Rodrigues ARA; Regasini LO; Andrade AA
J Appl Microbiol; 2019 Nov; 127(5):1362-1372. PubMed ID: 31297951
[TBL] [Abstract][Full Text] [Related]
48. A new antifungal macrolide, eushearilide, isolated from Eupenicillium shearii.
Hosoe T; Fukushima K; Takizawa K; Itabashi T; Kawahara N; Vidotto V; Kawai K
J Antibiot (Tokyo); 2006 Sep; 59(9):597-600. PubMed ID: 17136892
[TBL] [Abstract][Full Text] [Related]
49. Research on antifungal and antimycobacterial agents. Synthesis and activity of 4-alkylthiopyridine-2-carbothioamides.
Klimesová V; Svoboda M; Waisser K; Machácek M; Buchta V; Odlerová Z
Arch Pharm (Weinheim); 1996 Oct; 329(10):438-42. PubMed ID: 8933745
[TBL] [Abstract][Full Text] [Related]
50. In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test.
Nenoff P; Oswald U; Haustein UF
Mycoses; 1999; 42(11-12):629-39. PubMed ID: 10680439
[TBL] [Abstract][Full Text] [Related]
51. In vitro activity of 23 tea extractions and epigallocatechin gallate against Candida species.
Chen M; Zhai L; Arendrup MC
Med Mycol; 2015 Feb; 53(2):194-8. PubMed ID: 25605775
[TBL] [Abstract][Full Text] [Related]
52. Antifungal activity of a thiophene polyine from Leuzea carthamoides.
Chobot V; Buchta V; Jahodárová H; Pour M; Opletal L; Jahodár L; Harant P
Fitoterapia; 2003 Apr; 74(3):288-90. PubMed ID: 12727496
[TBL] [Abstract][Full Text] [Related]
53. Synthesis of chlorogenic acid derivatives with promising antifungal activity.
Ma CM; Kully M; Khan JK; Hattori M; Daneshtalab M
Bioorg Med Chem; 2007 Nov; 15(21):6830-3. PubMed ID: 17761420
[TBL] [Abstract][Full Text] [Related]
54. [Influence of the ecological group on the in vitro antifungal susceptibility of dermatophytic fungi].
Carrillo-Muñoz AJ; Tur-Tur C; Cárdenes D; Rojas F; Giusiano G
Rev Iberoam Micol; 2013; 30(2):130-3. PubMed ID: 23318162
[TBL] [Abstract][Full Text] [Related]
55. In vitro antifungal activity of CAN-296: a naturally occurring complex carbohydrate.
Ben-Josef AM; Manavathu EK; Platt D; Sobel JD
J Antibiot (Tokyo); 1997 Nov; 50(11):937-43. PubMed ID: 9592567
[TBL] [Abstract][Full Text] [Related]
56. Antifungal activity of 3-(heteroaryl-2-ylmethyl)thiazolidinone derivatives.
Marques GH; Kunzler A; Bareño VD; Drawanz BB; Mastelloto HG; Leite FR; Nascimento GG; Nascente PS; Siqueira GM; Cunico W
Med Chem; 2014 Jun; 10(4):355-60. PubMed ID: 23826891
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis, and structure-activity relationship studies of novel thienopyrrolidone derivatives with strong antifungal activity against Aspergillus fumigates.
Cao X; Xu Y; Cao Y; Wang R; Zhou R; Chu W; Yang Y
Eur J Med Chem; 2015 Sep; 102():471-6. PubMed ID: 26310892
[TBL] [Abstract][Full Text] [Related]
58. Studies on antifungal agents. 18. In vitro activity of 5,5-disubstituted-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methy lisoxazol idines and related compounds.
Mullen GB; DeCory TR; Allen SD; Mitchell JT; St Georgiev V
Chemotherapy; 1988; 34(6):444-7. PubMed ID: 2854041
[TBL] [Abstract][Full Text] [Related]
59. Design, synthesis, and structure-activity relationship studies of novel triazole agents with strong antifungal activity against Aspergillus fumigatus.
Ding Z; Ni T; Xie F; Hao Y; Yu S; Chai X; Jin Y; Wang T; Jiang Y; Zhang D
Bioorg Med Chem Lett; 2020 Feb; 30(4):126951. PubMed ID: 31926784
[TBL] [Abstract][Full Text] [Related]
60. Susceptibility of clinical isolates of yeasts to anti-fungal agents.
Hussain Qadri SM; Flournoy DJ; Qadri SG; Ramirez EG
Mycopathologia; 1986 Sep; 95(3):183-7. PubMed ID: 3773980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
